lipolysis comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-01-23. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
When a protein folds, the titratable amino acids in the protein are transferred from a solution-like environment to an environment determined by the 3-dimensional structure of the protein. For example, in an unfolded protein, an aspartic acid typically is in an environment which exposes the titratable side chain to water. When the protein folds, the aspartic acid could find itself buried deep in the protein interior with no exposure to solvent. Furthermore, in the folded protein, the aspartic acid will be closer to other titratable groups in the protein and will also interact with permanent charges (e.g. ions) and dipoles in the protein. All of these effects alter the pKa value of the amino acid side chain, and pKa calculation methods generally calculate the effect of the protein environment on the model pKa value of an amino acid side chain. Typically, the effects of the protein environment on the amino acid pKa value are divided into pH-independent effects and pH-dependent effects. The pH-independent effects (desolvation, interactions with permanent charges and dipoles) are added to the model pKa value to give the intrinsic pKa value. The pH-dependent effects cannot be added in the same straightforward way and have to be accounted for using Boltzmann summation, Tanford–Roxby iterations or other methods. The interplay of the intrinsic pKa values of a system with the electrostatic interaction energies between titratable groups can produce quite spectacular effects such as non-Henderson–Hasselbalch titration curves and even back-titration effects.
is less than 10.5, the blocks will mix and microphase separation is not observed. The incompatibility between the blocks also affects the solution behavior of these copolymers and their adsorption behavior on various surfaces. Block copolymers are able to self-assemble in selective solvents to form micelles among other structures. In thin films, block copolymers are of great interest as masks in the lithographic patterning of semiconductor materials for applications in high density data storage. A key challenge is to minimise the feature size and much research is in progress on this.
=== Legal definition === As of 23 November 2009, the Scotch Whisky Regulations 2009 (SWR) define and regulate the production, labelling, packaging as well as advertising of Scotch whisky in the United Kingdom. They replace previous regulations that focused solely on production, including the Scotch Whisky Act 1988. Since the previous act focused primarily on production standards, it was repealed and superseded by the 2009 Regulations. The SWR includes broader definitions and requirements for the crafting, bottling, labelling, branding, and selling of "Scotch Whisky". International trade agreements have the effect of making some provisions of the SWR apply in various other countries as well as in the UK. The SWR defines "Scotch whisky" as whisky that:
Sources: en.wikipedia.org
=== The socialist project === The political program developed by the governments presided by Felipe González was not a project of "socialist transformation" but of "modernization" of Spanish society to put it on a par with the rest of the "advanced" democratic societies. The PSOE's electoral program was very ambitious as it aimed to consolidate democracy and face the economic crisis as well as to adapt the productive structures to a more efficient and competitive economy and to achieve a fairer and more egalitarian society with the universalization of health, education and pensions. This was synthesized in the slogan "Que España funcione" ("Let Spain work") thanks to a "gobierno que gobierna" ("government that governs"). However, the economic and political situation that Calvo Sotelo's government bequeathed to him was very complicated. Economic stagnation continued, with unemployment exceeding 16%, inflation not falling below 15% and a runaway budget deficit. ETA activity continued and the threat of a coup had not disappeared.
== South Africa == In 1996 the main laboratory moved to Richmond and could provide services to the Gauteng region. In 2000 it merged with the Pillay MacIntosh practice in Durban. Eftyhia Vardas is the head of virology at the Lancet in Johannesburg. In November 2021, Alison J. Glass, a clinical virologist at the lab reported that observations made by one of their junior scientists led to the discovery of the omicron variant of the COVID-19 virus. The laboratory sent samples to the Network for Genomic Surveillance in South Africa, of which the Lancet is a part and whose principal investigator, Tulio de Oliveira, confirmed and announced the findings following further investigation.
== General biochemistry concepts == Major categories of bio-compounds: Carbohydrates : sugar – disaccharide – polysaccharide – starch – glycogen Lipids : fatty acid – fats – essential oils – oils – waxes – cholesterol Nucleic acids : DNA – RNA – mRNA – tRNA – rRNA – codon – adenosine – cytosine – guanine – thymine – uracil Proteins : amino acid – glycine – arginine – lysine peptide – primary structure – secondary structure – tertiary structure – conformation – protein folding Chemical properties: molecular bond – covalent bond – ionic bond – hydrogen bond – ester – ethyl molecular charge – hydrophilic – hydrophobic – polar pH – acid – alkaline – base oxidation – reduction – hydrolysis Structural compounds: In cells: flagellin – peptidoglycan – myelin – actin – myosin In animals: chitin – keratin – collagen – silk In plants: cellulose – lignin – cell wall Enzymes and enzyme activity: enzyme kinetics – enzyme inhibition proteolysis – ubiquitin – proteasome kinase – dehydrogenase Membranes : fluid mosaic model – diffusion – osmosis phospholipids – glycolipid – glycocalyx – antigen – isoprene ion channel – proton pump – electron transport – ion gradient – antiporter – symporter – quinone – riboflavin Biomolecule (list) Biomolecular engineering Biomolecular structure Multi-state modeling of biomolecules Energy pathways : pigments : chlorophyll – carotenoids – xanthophyll – cytochrome – phycobilin – bacteriorhodopsin – hemoglobin – myoglobin – absorption spectrum – action spectrum – fluorescence Photosynthesis : light reaction – dark reaction Fermentation : Acetyl-CoA – lactic acid Cellular respiration : Adenosine triphosphate (ATP) – NADH – pyruvate – oxalate – citrate Chemosynthesis Regulation hormones : auxin signal transduction – growth factor – transcription factor – protein kinase – SH3 domain Malfunctions : tumor – oncogene – tumor suppressor gene Receptors : Integrin – transmembrane receptor – ion channel Techniques : electrophoresis – chromatography – mass spectrometry – x-ray diffraction – Southern blot – fractionation – Gram stain – Surface Plasmon Resonance – Microscale Thermophoresis
=== Lipids === An indication of the role of high-density lipoprotein (HDL) on atherosclerosis has been with the rare Apo-A1 Milano human genetic variant of this HDL protein. A small short-term trial using bacterial-synthesized human Apo-A1 Milano HDL in people with unstable angina produced a fairly dramatic reduction in measured coronary plaque volume in only six weeks vs. the usual increase in plaque volume in those randomized to placebo. The trial was published in JAMA in early 2006. Ongoing work starting in the 1990s may lead to human clinical trials—probably by about 2008. These may use synthesized Apo-A1 Milano HDL directly, or they may use gene-transfer methods to pass the ability to synthesize the Apo-A1 Milano HDLipoprotein. Methods to increase HDL particle concentrations, which in some animal studies largely reverse and remove atheromas, are being developed and researched. However, increasing HDL by any means is not necessarily helpful. For example, the drug torcetrapib is the most effective agent currently known for raising HDL (by up to 60%). However, in clinical trials, it also raised deaths by 60%. All studies regarding this drug were halted in December 2006. The actions of macrophages drive atherosclerotic plaque progression. Immunomodulation of atherosclerosis is the term for techniques that modulate immune system function to suppress this macrophage action.
Sources: en.wikipedia.org
233U(22Ne,xn)255−xNo The synthesis of neutron deficient nobelium isotopes was studied in 1975 at the FLNR. In their experiments they observed a 250 s SF activity, which they tentatively assigned to 250No in the 5n exit channel. Later results have not been able to confirm this activity and it is currently unidentified.
=== Pharmacodynamics === The measurement of plasma uric acid was used to evaluate the effectiveness of rasburicase in clinical studies. Following administration of either 0.15 or 0.20 mg/kg rasburicase daily for up to 5 days, plasma uric acid levels decreased within 4 hours and were maintained below 7.5 mg/dL in 98% of adult and 90% of pediatric patients for at least 7 days. There was no evidence of a dose response effect on uric acid control for doses between 0.15 and 0.20 mg/kg rasburicase.
On 11 December, they sent a telegram to People's Liberation Army (PLA) commander Zhu De, backdated to the 9th, officially breaking ties with the Kuomintang and joining the communists under Mao Zedong. This event was known as the Chengdu Uprising.
=== Burns === The Healing Foundation facilitated the establishment of two research centres dedicated to burns. The first, situated at Frenchay Hospital in Bristol, aimed to develop innovative techniques for burn prevention and enhance clinical care for affected children. The Centre for Children's Burns Research was officially opened in June 2013 by Sophie, Duchess of Edinburgh. Subsequently, another research hub, the Healing Foundation Centre for Burns Research, was inaugurated at Queen Elizabeth Hospital in Birmingham in October 2013. A notable outcome of The Healing Foundation Centre for Children's Burns Research was the SmartWound PREDICT Dressing, developed by scientists at the University of Bath. This dressing changes colour upon detecting bacteria, providing an alternative method for infection detection.
The stores, which made less than half the average company per-store sales, were concentrated heavily in the areas around Providence, Rhode Island, and Hartford, Connecticut, the former of which also has a concentration of stores from the locally competing Honey Dew Donuts chain, with some 150 outlets in Rhode Island and Southeastern Massachusetts. In the announcement, the chain stated that it will concentrate its efforts on its core markets such as western Canada. In the same statement, the company announced the sale of its portion of distribution company Maidstone Bakeries to Tim Hortons' European partners. It will use the CA$400 million generated by the sale for a stock buyback.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.